145 related articles for article (PubMed ID: 34764094)
1. Intravitreal dexamethasone implant use as first-line therapy for cancer-associated retinopathy.
Mudri J; Phagura RS; Lam WS; Wu XN
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764094
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Dexamethasone Implant with Plasma Autoantibody Monitoring for Cancer-associated Retinopathy.
Kim MS; Hong HK; Park KH; Woo SJ
Korean J Ophthalmol; 2019 Jun; 33(3):298-300. PubMed ID: 31179664
[No Abstract] [Full Text] [Related]
5. Electroretinographic Findings in Melanoma-Associated Retinopathy Treated by Intravitreal Dexamethasone Implant.
Abou-Samra A; Tzekov R; Yannuzzi NA; Tarabishy AB
Ophthalmic Surg Lasers Imaging Retina; 2021 Aug; 52(8):454-456. PubMed ID: 34410186
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
7. Cystoid macular edema from cancer-associated retinopathy.
Moyer K; DeWilde A; Law C
Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S66-70. PubMed ID: 24531653
[TBL] [Abstract][Full Text] [Related]
8. A slow-release dexamethasone implant for cancer-associated retinopathy.
Chaves LJ; Albuquerque ML; Schnorr A; Cyrino F; Habib ML; Messias A; Correa ZM; Jorge R
Arq Bras Oftalmol; 2023; 86(2):171-174. PubMed ID: 35170652
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.
Nghiem-Buffet S; Baillif S; Regnier S; Skelly A; Yu N; Sodi A
Eye (Lond); 2017 Apr; 31(4):551-559. PubMed ID: 27911446
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
Kong X; Psaras C; Stewart JM
Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
[TBL] [Abstract][Full Text] [Related]
12. Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach.
Giovannini A; Parravano M; Ricci F; Bandello F
Eur J Ophthalmol; 2019 Jan; 29(1):82-91. PubMed ID: 29882421
[TBL] [Abstract][Full Text] [Related]
13. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of Clinically Diagnosed Cancer-Associated Retinopathy with Intravitreal Dexamethasone Implant Followed by 0.18 mg Fluocinolone Implant without Systemic Immunosuppression.
Huang L; Yang P; Flaxel C; Suhler E; Lin P
Retin Cases Brief Rep; 2024 Feb; ():. PubMed ID: 38386915
[TBL] [Abstract][Full Text] [Related]
15. Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study.
Sharma A; Bandello F; Loewenstein A; Kuppermann BD; Lanzetta P; Zur D; Hilely A; Iglicki M; Veritti D; Wang A; Miassi F; Bellocq D; Zacharias LC; Makam D; Kumar N; Parachuri N; Barriera AK; Sharma R; Faridi H; Mathis T; Kodjikian L
Int Ophthalmol; 2020 Nov; 40(11):3067-3075. PubMed ID: 32613461
[TBL] [Abstract][Full Text] [Related]
16. ACUTE ZONAL OCCULT OUTER RETINOPATHY: A CASE REPORT OF REGRESSION AFTER AN INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANT.
Vadboncoeur J; Jampol LM; Goldstein DA
Retin Cases Brief Rep; 2022 Jul; 16(4):466-469. PubMed ID: 32541439
[TBL] [Abstract][Full Text] [Related]
17. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.
Ciulla TA; Harris A; McIntyre N; Jonescu-Cuypers C
Expert Opin Pharmacother; 2014 May; 15(7):953-9. PubMed ID: 24661081
[TBL] [Abstract][Full Text] [Related]
18. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review.
Ahn SJ; Joung J; Lee SH; Lee BR
BMC Ophthalmol; 2018 Dec; 18(1):310. PubMed ID: 30522457
[TBL] [Abstract][Full Text] [Related]
20. Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone.
Poujade L; Samaran Q; Mura F; Guillot B; Meunier I; Du-Thanh A
Doc Ophthalmol; 2021 Apr; 142(2):257-263. PubMed ID: 32975694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
